EMEA-000380-PIP01-08-M04

  • Email
  • Help

Overview

Product details for Cosentyx
Invented nameCosentyx
Active substance

Secukinumab

Decision numberP/0352/2017
PIP numberEMEA-000380-PIP01-08-M04
Pharmaceutical form(s)Powder for solution for injection; Solution for injection
Condition(s)/indication(s)

Treatment of psoriasis

Route(s) of administrationSubcutaneous use
PIP applicant

Novartis Europharm Ltd
Tel. +41 613249752
E-mail: paediatric.enquiries@novartis.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision